Finance

Lists
Q1 2027 earnings • released • Revenue beat +11.07%
See results
6869:TYO
Sysmex Corp
¥1,980.00
+19.89%
(+328.50) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6869...
Open
¥1,925
High
¥1,986
Low
¥1,917
Mkt. cap
1.25T
Avg. vol.
2.65M
Volume
11.98M
Dividend
1.82%
Quarterly dividend
¥9
Ex-dividend date
Sep 29, 2026
P/E ratio
31.06
52-wk high
¥2,086
52-wk low
¥1,246
EPS
¥64
Shares outstanding
208.64M
No. of employees
11K
Open
¥1,925
High
¥1,986
Low
¥1,917
Mkt. cap
1.25T
Avg. vol.
2.65M
Volume
11.98M
Dividend
1.82%
Quarterly dividend
¥9
Ex-dividend date
Sep 29, 2026
P/E ratio
31.06
52-wk high
¥2,086
52-wk low
¥1,246
EPS
¥64
Shares outstanding
208.64M
No. of employees
11K
News stories
From web sources and news partners
Profile
Sysmex Corporation is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers. The company was renamed Sysmex Corporation in 1998 taking advantage of brand recognition of their machines. Wikipedia
About Sysmex Corp
CEOHisashi Ietsugu
Employees10.9K
FoundedFeb 20, 1968
HeadquartersKobe, Hyogo, Japan
SectorMedical device
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
130.67B / 117.65B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
126.80B
128.64B
138.84B
130.67B
Cost of goods sold
58.70B
63.57B
70.79B
64.36B
Cost of revenue
58.70B
63.57B
70.79B
64.36B
Research and development expenses
6.80B
7.24B
-20.44B
7.21B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.58B
42.33B
73.31B
42.61B
Operating expense
45.76B
49.38B
53.20B
51.49B
Total operating expenses
104.47B
112.94B
123.99B
115.85B
Operating income
22.33B
15.70B
14.85B
14.82B
Other non operating income
-1.00M
3.00M
-640.00M
-1.00M
EBT including unusual items
22.08B
17.52B
1.58B
14.11B
EBT excluding unusual items
22.08B
17.52B
14.70B
14.11B
Income tax expense
7.70B
2.86B
-272.00M
5.49B
Effective tax rate
34.85%
16.30%
-17.22%
38.94%
Other operating expenses
-609.00M
-199.00M
337.00M
1.66B
Net income
14.47B
14.68B
1.76B
8.69B
Net profit margin
11.41%
11.41%
1.27%
6.65%
Earnings per share
-
-
-
-
Interest and investment income
243.00M
270.00M
541.00M
245.00M
Interest expense
-905.00M
-847.00M
-
-1.27B
Net interest expenses
-662.00M
-577.00M
541.00M
-1.03B
Depreciation and amortization charges
-
-
-
-
EBITDA
34.40B
27.69B
26.47B
26.85B
Gain or loss from assets sale
100.00M
463.00M
11.72B
148.00M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps